Company intelligence / Profile preview

Rose Research Center

Raleigh, North Carolina, United Statesroseresearchcenter.com ↗

Ownership: Private
Development stage: Commercial

Overview

Rose Research Center is a state-of-the-art clinical research facility specializing in tobacco dependence, addiction, smoking cessation, and tobacco harm reduction. It conducts medically supervised clinical trials to determine the safety and efficacy of new pharmaceuticals for these indications. Current studies include evaluating combination therapies for aiding smokers in switching to e-cigarettes or quitting entirely. The center has a strong focus on rigorous study design, participant recruitment/retention, and data management.

Therapeutic areas: PulmonologyPsychiatry
Modalities: Small moleculeCombination therapy
Industry: Contract Research Organization

Beyond the preview

Go deeper on Rose Research Center.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rose Research Center.